Alisporivir Completed Phase 3 Trials for Hepatitis C Viral Infection

IndicationsStatusPurposePhase
CompletedNot Available3
clinicaltrials.gov IdentifierTitleDrugs
NCT02753699Long Term Follow-up Study to Assess Durability of Sustained Virologic Response in Alisporivir-treated Hepatitis C Patients